Laura Esparcia-Pinedo

Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer

A. Alfranca, N. Romero-Laorden, L. Esparcia-Pinedo, 2023, Frontiers in immunology.

Imbalance of SARS-CoV-2-specific CCR6+ and CXCR3+ CD4+ T cells and IFN-γ + CD8+ T cells in patients with Long-COVID.

A. Alfranca, H. de la Fuente, J. Galván-Román, 2024, Clinical Immunology.

T regulatory lymphocytes specific for SARS-CoV-2 display increased functional plasticity.

A. Alfranca, E. Martín-Gayo, P. Martínez-Fleta, 2023, Clinical immunology.

Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis

I. González-Álvaro, A. Alfranca, E. Vicente-Rabaneda, 2024, NPJ vaccines.

Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs

F. Sánchez‐Madrid, A. Alfranca, V. Meca-Lallana, 2023, Clinical Immunology Communications.

The age again in the eye of the COVID-19 storm: evidence-based decision making

R. Rojo, D. San Segundo, M. López-Hoyos, 2021, Immunity & ageing : I & A.